These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33410265)

  • 21. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
    Naumann M; Lowe NJ
    BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study.
    Lueangarun S; Sermsilp C; Tempark T
    Dermatol Surg; 2018 Aug; 44(8):1094-1101. PubMed ID: 29659406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial.
    Szeimies RM; Abels C; Kilic A; Reich H; Berger B; Schulze Zur Wiesche E; Schramm K; Litzka L; Heimstaedt-Muskett S; Masur C
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):823-830. PubMed ID: 36606529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study between intradermal botulinum toxin A and fractional microneedle radiofrequency (FMR) for the treatment of primary axillary hyperhidrosis.
    Rummaneethorn P; Chalermchai T
    Lasers Med Sci; 2020 Jul; 35(5):1179-1184. PubMed ID: 31939036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of microwave thermolysis energy levels on patient-reported outcomes for axillary hyperhidrosis and osmidrosis.
    Grove GL; Togsverd-Bo K; Schwensen JFB; Andersson NW; Nissen CV; Zachariae C; Haedersdal M
    Lasers Surg Med; 2023 Jan; 55(1):105-115. PubMed ID: 36229952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Phase 3, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Neu-BoNT/A in Treatment of Primary Axillary Hyperhidrosis.
    Lee DG; Kim JE; Lee WS; Kim MB; Huh CH; Lee YW; Choi GS; Lee JB; Yu DS; Shin MK; Roh MR; Ahn HH; Kim WS; Lee JH; Park KY; Park J; Lee WJ; Park MY; Kang H
    Aesthetic Plast Surg; 2022 Jun; 46(3):1400-1406. PubMed ID: 35132458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and histological evaluation of a single high energy microwave treatment for primary axillary hyperhidrosis in Asians: A prospective, randomized, controlled, split-area comparative trial.
    Kaminaka C; Mikita N; Inaba Y; Kunimoto K; Okuhira H; Jinnin M; Kao B; Tanino R; Tanioka K; Shimokawa T; Yamamoto Y
    Lasers Surg Med; 2019 Sep; 51(7):592-599. PubMed ID: 30811620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.
    Glogau RG
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S76-80. PubMed ID: 17241418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study.
    Glaser DA; Coleman WP; Fan LK; Kaminer MS; Kilmer SL; Nossa R; Smith SR; O'Shaughnessy KF
    Dermatol Surg; 2012 Feb; 38(2):185-91. PubMed ID: 22289389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
    Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SUPPLEMENT ARTICLE: A Novel Drug Delivery Method: Retrometabolic Drug Design.
    Armstrong A; Reddy R; Chadha D; Kircik L
    J Drugs Dermatol; 2022 Apr; 21(4):s5-s10. PubMed ID: 35389593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments.
    Lowe PL; Cerdan-Sanz S; Lowe NJ
    Dermatol Surg; 2003 May; 29(5):545-8. PubMed ID: 12752526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of topical formulations containing 0·5, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double-blind, placebo-controlled study.
    Masur C; Soeberdt M; Kilic A; Knie U; Abels C
    Br J Dermatol; 2020 Jan; 182(1):229-231. PubMed ID: 31218668
    [No Abstract]   [Full Text] [Related]  

  • 39. Fractionated microneedle radiofrequency for treatment of primary axillary hyperhidrosis: A sham control study.
    Fatemi Naeini F; Abtahi-Naeini B; Pourazizi M; Nilforoushzadeh MA; Mirmohammadkhani M
    Australas J Dermatol; 2015 Nov; 56(4):279-84. PubMed ID: 25496000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M; Plewig G;
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.